Alzheimer's disease

D&D bags $137M to fund midphase Alzheimer's, Parkinson's trials
D&D bags $137M to fund midphase Alzheimer's, Parkinson's trials
Fierce Biotech
D&D Pharmatech
neurodegenerative disease
Alzheimer's disease
Parkinson's Disease
Flag link:
Is a Low-Cost Blood Test for Alzheimer's on the Horizon?
Is a Low-Cost Blood Test for Alzheimer's on the Horizon?
BioSpace
diagnostics
Alzheimer's disease
Washington University
Flag link:
Scientists close in on blood test for Alzheimer’s
Scientists close in on blood test for Alzheimer’s
Stat
Alzheimer's disease
dementia
diagnostics
Flag link:
Neon and Neurotrope await signs of proof of concept
Neon and Neurotrope await signs of proof of concept
EP Vantage
Neon Therapeutics
neoantigens
Neurotrope BioScience
Alzheimer's disease
Flag link:
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Alzheimer's disease
BACE inhibitors
Merck
Eli Lilly
AstraZeneca
Amgen
Novartis
Biogen Eisai
Flag link:
Tiaki hires Bruhn as CEO for Alzheimer's drug discovery push
Tiaki hires Bruhn as CEO for Alzheimer's drug discovery push
Fierce Biotech
Tiaki Therapeutics
Suzanne Bruhn
Alzheimer's disease
Flag link:
Dementia tied to hormone-blocking prostate cancer treatment
Dementia tied to hormone-blocking prostate cancer treatment
Yahoo/AP
Alzheimer's disease
prostate cancer
Flag link:
New Markers For Alzheimer's Disease Could Aid Diagnosis And Speed Up Drug Development
New Markers For Alzheimer's Disease Could Aid Diagnosis And Speed Up Drug Development
NPR
Alzheimer's disease
biomarkers
drug develoment
R&D
diagnostics
Flag link:
Denovo Biopharma Acquires Global Rights to Experimental Alzheimer’s Drug
Denovo Biopharma Acquires Global Rights to Experimental Alzheimer’s Drug
BioSpace
DeNovo
Alzheimer's disease
ORM-12741
Flag link:
Karuna Therapeutics Raises Its IPO Estimate to $85 Million
Karuna Therapeutics Raises Its IPO Estimate to $85 Million
CP Wire
Karuna Therapeutics
IPOs
schizophrenia
Alzheimer's disease
Flag link:
Karuna Therapeutics Raises Its IPO Estimate to $85 Million
Karuna
schizophrenia
Alzheimer's disease
Flag link:
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures
Investors Business Daily
Alzheimer's disease
drug development
Biogen
Eisai
Flag link:
Research Roundup: A New Protein Linked to Alzheimer’s and Other Highlights
Research Roundup: A New Protein Linked to Alzheimer’s and Other Highlights
BioSpace
R&D
Alzheimer's disease
genetic translation
Flag link:
A Missed Alzheimer’s Opportunity? Not So Much
A Missed Alzheimer’s Opportunity? Not So Much
In the Pipeline
Pfizer
Enbrel
Alzheimer's disease
social media
clinical trials
journalism
Flag link:
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world?
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world?
Washington Post, DC
Pfizer
Enbrel
Alzheimer's disease
Flag link:
Could This Blood Test Revolutionise How Dementia and Other Neurodegenerative Diseases Are Diagnosed?
Could This Blood Test Revolutionise How Dementia and Other Neurodegenerative Diseases Are Diagnosed?
Forbes
Alzheimer's disease
dementia
neurodegenerative disease
Enya Labs
diagnostics
Flag link:
T3D Therapeutics Receives $9 Million NIH Grant to Advance Alzheimer's Clinical Trial
T3D Therapeutics Receives $9 Million NIH Grant to Advance Alzheimer's Clinical Trial
BioSpace
T3D Therapeutics
NIH
Alzheimer's disease
clinical trials
T3D-959
Flag link:
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Alzheimer's disease
drug development
aducanumab
Biogen
Eisai
BAN2401
Merck
Eli Lilly
AstraZeneca
Flag link:
Merck Ready to Submit Belsomra to FDA for Alzheimer's Insomnia
Merck Ready to Submit Belsomra to FDA for Alzheimer's Insomnia
BioSpace
Merck
Belsomra
insomnia
Alzheimer's disease
Flag link:
Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs
Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs
BioSpace
Eisai
Biogen
Alzheimer's disease
R&D
aducanumab
BAN2401
Flag link:

Pages